Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-021981

President and CEO gave up 5,787 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Luly Jay R. President and CEO 2023-12-01 Shares withheld for taxes −5,787 $9.49 $54,919 814,023 D
Loading xslF345X05/form4.xml…